Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04237584
Title A Study Comparing ARB With Radium-223 vs ARB Therapy With Placebo and the Effect Upon Survival for mCRPC Patients (ESCALATE)
Recruitment Terminated
Gender male
Phase Phase III
Variant Requirements No
Sponsors MANA RBM
Indications

prostate adenocarcinoma

Therapies

Darolutamide

Darolutamide + Radium Ra 223 dichloride

Enzalutamide

Enzalutamide + Radium Ra 223 dichloride

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.